CITATION STYLE
Gillmore, J. D., Falk, R. H., Maurer, M. S., Hanna, M., Karsten, V., Vest, J., … Hawkins, P. N. (2015). Phase 2, open-label extension (OLE) study of revusiran, an investigational RNAi therapeutic for the treatment of patients with transthyretin cardiac amyloidosis. Orphanet Journal of Rare Diseases, 10, 1–2. https://doi.org/10.1186/1750-1172-10-S1-O21
Mendeley helps you to discover research relevant for your work.